Issue Information.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3045
- Publication type:
- Article
Works matching IS 1099498X AND DT 2018 AND VI 20 AND IP 7/8
Results: 7
1
2
Epidermal growth factor receptor targeted methotrexate and small interfering RNA co‐delivery.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3041
- By:
- Publication type:
- Article
3
Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3028
- By:
- Publication type:
- Article
4
Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti‐Her2 chimeric antigen receptor gene.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3027
- By:
- Publication type:
- Article
5
Human interleukin‐10 delivered intrathecally by self‐complementary adeno‐associated virus 8 induces xenogeneic transgene immunity without clinical neurotoxicity in swine.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3026
- By:
- Publication type:
- Article
6
Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3025
- By:
- Publication type:
- Article
7
Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
- Published in:
- Journal of Gene Medicine, 2018, v. 20, n. 7/8, p. 1, doi. 10.1002/jgm.3023
- By:
- Publication type:
- Article